P
Phillip Wong
H指数:46
被引数:2.3万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial
不可切除的III期非小细胞肺癌中,Canakinumab联合化放疗和Durvalumab巩固治疗:CHORUS I/II期试验
Nature Communications
IF15.7
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma
在去分化脂肪肉瘤中序贯使用CDK4/6和PD-1抑制剂后的肿瘤与免疫动态变化:一项2期研究的结果
Efficacy and Efficiency of In-House Clear Aligners in Limited Orthodontic Treatment
院内定制隐形矫治器的效能与效率在有限正畸治疗中的应用
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer
SARS-CoV-2感染导致免疫缺陷癌症患者肠道上皮局部炎症
iScience
IF4.1
Patient perceptions of empathy in physician and artificial intelligence chatbot responses to patient questions about cancer
患者对医生和人工智能聊天机器人在回应癌症患者问题时的共情感知
NPJ DIGITAL MEDICINE
IF15.1
Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
外周血(PB)T细胞表型和肿瘤微环境(TME)亚型与肉瘤中免疫检查点阻断(ICB)的疗效独立相关
ANNALS OF ONCOLOGY
IF65.4
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma
用肿瘤治疗场 (TTFields) 治疗在恶性间皮瘤中抑制细胞间隧道纳米管的形成并在体内上调免疫肿瘤学生物标志物
ELIFE
IF0
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
全基因组无细胞DNA突变整合可实现超灵敏的癌症监测
NATURE MEDICINE
IF50

